VCEL logo
VCEL NASDAQ US

Vericel Corporation - Common Stock

Healthcare · Biotechnology Website · IPO Feb 1997
$34.14
▲ +$1.58 (+4.85%)
Vol 1.7M
10
Quality Score
ok
Deep Check
1/5 fail
Mkt Cap
$1.8B
P/E
139.2
ROE
4.3%
Margin
5.1%
D/E
0.20
Beta
1.25
52W
$29–$63

Wall Street Consensus

14 analysts · Apr 2026
5
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

VRDN
Viridian Therapeutics Inc
$3.0B
CAPR
Capricor Therapeutics Inc
$1.6B
SION
Sionna Therapeutics Inc
$1.8B
PVLA
Palvella Therapeutics Inc
$1.2B
ZYME
Zymeworks Inc
$2.0B
ANAB
AnaptysBio Inc
$1.3B
RXRX
Recursion Pharmaceuticals Inc
$2.1B
NRIX
Nurix Therapeutics Inc
$1.9B

Earnings

Beat rate: 75.0%
Next Report May 06, 2026
EPS Estimate: $-0.16
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.16 — —
Dec 2025 $0.40 $0.45 +$0.05
Sep 2025 $-0.01 $0.10 +$0.11
Jun 2025 $-0.03 $-0.01 +$0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 2.5% 2.5% 2.5% 2.5% 4.3% 4.3%
P/E (TTM) 301.41 258.73 219.46 248.93 145.55 139.21
Net Margin -0.9% 2.9% 2.9% 2.9% 5.1% 5.1%
Gross Margin 73.7% 73.5% 73.5% 73.5% 73.8% 73.8%
D/E Ratio 0.58 0.58 0.58 0.58 0.20 0.20
Current Ratio 4.97 4.97 4.97 4.97 4.87 4.87

Key Ratios

ROA (TTM)
3.0%
P/S (TTM)
7.04
P/B
9.3
EPS (TTM)
$0.19
CF/Share
$-0.12
Rev Growth 3Y
+15.0%
52W High
$63.00
52W Low
$29.24
$29.24 52-Week Range $63.00

How does VCEL compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

VCEL AAPG ABEO ABOS ABP

VCEL valuation vs Biotechnology peers

P/E ratio
139.2
▲ 641% above peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
7.0
▼ 45% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
9.3
▲ 277% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

VCEL profitability vs Biotechnology peers

ROE
4.3%
▲ 106% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
5.1%
▲ 102% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
73.8%
▼ 6% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
3.0%
▲ 106% above peers (-46.7%)
vs Peers
vs Industry
Top tier

VCEL financial health vs Biotechnology peers

D/E ratio
0.2
▼ 0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
4.9
▲ 10% above peers (4.4)
vs Peers
vs Industry
In line
Beta
1.3
▲ 29% above peers (1.0)
vs Peers
vs Industry
More volatile

VCEL fundamentals radar

VCEL Peer median Industry

VCEL profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

VCEL vs peers: key metrics

Latest News

No related news yet